2019年罗氏制药日

网络直播回放

请注册访问重播*

第一个名字

姓

公司电子邮件

公司名称

确认你是人类*

该测试要求您同意锁定cookie

*注意隐私

主旨演讲

Morning session","",""],["Welcome\nKarl Mahler, Head of Investor Relations","PDF",""],["Pharma strategy, Portfolio planning, Productivity and new technologies\nBill Anderson, CEO Roche Pharmaceuticals","PDF",""],["Market opportunities; Pricing & Access\nTeresa Graham, Head Global Product Strategy","PDF",""],["Oncology franchise\nSandra Horning, Chief Medical Officer and Head Global Product Development","PDF",""],["Neuroscience franchise\nPaulo Fontoura, Global Head Neuroscience and Rare Diseases Clinical Development","PDF",""],["Afternoon sessions (breakouts)","",""],["Immunology & Infectious diseases\nCristin Hubbard, Senior Vice President, Global Product Strategy, Immunology, Infections Diseases and Ophthalmology\nZafar Hakim, Senior Director, Disease Area Strategy Immunology, Infectious Diseases & Ophthalmology, Global Product Strategy","PDF","MP3"],["Late stage pipeline Ophthalmology\nAtul Dandekar Ophthalmology Franchise Head in Global Product Strategy\nSascha Fauser, Head of Ophthalmology group (Discovery and Translational Medicine)","PDF","MP3"],["Digitalisation & Personalized healthcare\nBryn Roberts Global Head of Operations & Informatics for Pharma Research and Early Development","PDF","MP3"],["Appendix","",""],["Pipeline overview\t","PDF",""],["Patient populations\t","PDF",""]]" slot="left" uid="56884e70-ae04-4270-9306-701fcb817060" id="56884e70-ae04-4270-9306-701fcb817060" storyid="79163036" class="sc-roche-responsive-table-h hydrated">

主题-主讲人

早上的会议

欢迎卡尔·马勒，投资者关系主管

制药战略，投资组合规划，生产力和新技术Bill Anderson，罗氏制药首席执行官

市场机会;Teresa Graham，全球产品战略主管

肿瘤学特许经营Sandra Horning，首席医疗官和全球产品开发主管

神经科学特许经营保罗·丰图拉，神经科学和罕见疾病临床开发全球负责人

下午分组(分组)

Cristin Hubbard，免疫、传染病和眼科全球产品战略高级副总裁Zafar Hakim，疾病领域战略免疫、传染病和眼科全球产品战略高级总监

全球产品战略眼科特许经营主管Sascha Fauser，眼科集团(发现和转化医学)负责人

Bryn Roberts制药研究和早期开发运营与信息学全球主管

附录

管道概述

患者群体

演讲

PDF

音频回放

MP3

投资者

过去的IR事件

查看更多事件

罗氏于2019年9月16日(星期一)为分析师和投资者举办了一场活动。

爱游戏ayx官方

网络直播回放

主旨演讲

过去的IR事件

相关链接